These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6372069)

  • 41. [Background and experience of adjuvant cytostatic therapy in gastrointestinal cancer (author's transl)].
    Hafström L; Bengmark S; Eriksson S; Hugander A
    Zentralbl Chir; 1981; 106(19):1284-8. PubMed ID: 7034399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chemotherapy of cancer of the large intestine].
    Platinskiĭ LV; Sokolova VD; Ozhiganov EL
    Sov Med; 1985; (3):51-8. PubMed ID: 3895460
    [No Abstract]   [Full Text] [Related]  

  • 43. A comparison of two dose regimens in pancreatic cancer.
    Figer A; Sadikov E; Mishaeli M; Koren R; Gal R; Levin I; Klein B
    J Chemother; 2000 Oct; 12(5):442-5. PubMed ID: 11128566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
    Punt CJ; van Herpen CM; Jansen RL; Vreugdenhil G; Muller EW; de Mulder PH
    Br J Cancer; 1997; 76(2):266-9. PubMed ID: 9231931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
    Webre C; Shonka N; Smith L; Liu D; De Groot J
    Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience.
    Cornwell GG; Pajak TF; Kochwa S; McIntyre OR; Glowienka LP; Brunner K; Rafla S; Coleman M; Cooper MR; Henderson E
    J Clin Oncol; 1988 Sep; 6(9):1481-90. PubMed ID: 3047338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
    Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
    J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II study of procarbazine, CCNU, and vincristine combination chemotherapy in the treatment of malignant brain tumors.
    Gutin PH; Wilson CB; Kumar AR; Boldrey EB; Levin V; Powell M; Enot KJ
    Cancer; 1975 May; 35(5):1398-404. PubMed ID: 1122488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.
    Evans AE; Jenkin RD; Sposto R; Ortega JA; Wilson CB; Wara W; Ertel IJ; Kramer S; Chang CH; Leikin SL
    J Neurosurg; 1990 Apr; 72(4):572-82. PubMed ID: 2319316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II trial of 5-FU, vincristine, and mitomycin (FOMi) in metastatic bronchioloalveolar cell lung cancer: a Southwest Oncology Group Study.
    Miller TP; Livingston RB
    Cancer Treat Rep; 1985 Nov; 69(11):1313-4. PubMed ID: 3004726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
    Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
    J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modern problems of clinical chemotherapy of malignant tumours.
    Perevodchikova NI; Bychkov MB
    Arch Geschwulstforsch; 1980; 50(7):657-63. PubMed ID: 6263209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methyl-CCNU, 5-fluorouracil, vincristine, and streptozocin (MOF-STREP) in metastatic colo-rectal carcinoma.
    Weltz MD; Perry DJ; Blom J; Butler WM
    J Clin Oncol; 1983 Feb; 1(2):135-7. PubMed ID: 6230421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined modality treatment of operated astrocytomas grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy. Stage II of a prospective multicenter trial of the Scandinavian Glioblastoma Study Group.
    Hatlevoll R; Lindegaard KF; Hagen S; Kristiansen K; Nesbakken R; Torvik A; Ganz JC; Mella O; Rosengren B; Ringkjöb R
    Cancer; 1985 Jul; 56(1):41-7. PubMed ID: 2988737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trial.
    Chlebowski RT; Pugh R; Weiner JM; Block JB; Bateman JR
    Cancer; 1983 Aug; 52(4):606-9. PubMed ID: 6344982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical study on the effect of chemotherapy in the treatment of pancreatic cancer].
    Yamamoto M; Saitoh Y; Ohyanagi H; Ishida T; Shimada Y; Tagashira Y; Fujimoto T; Kurogoh F; Okumura S; Uchida K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):703-7. PubMed ID: 3128183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.